Michael D. Diamantidis

626 total citations
43 papers, 311 citations indexed

About

Michael D. Diamantidis is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Michael D. Diamantidis has authored 43 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 17 papers in Genetics and 8 papers in Molecular Biology. Recurrent topics in Michael D. Diamantidis's work include Hemoglobinopathies and Related Disorders (15 papers), Iron Metabolism and Disorders (13 papers) and Acute Myeloid Leukemia Research (10 papers). Michael D. Diamantidis is often cited by papers focused on Hemoglobinopathies and Related Disorders (15 papers), Iron Metabolism and Disorders (13 papers) and Acute Myeloid Leukemia Research (10 papers). Michael D. Diamantidis collaborates with scholars based in Greece, United States and United Kingdom. Michael D. Diamantidis's co-authors include Georgia Kaiafa, Zisis Kontoninas, Efthymia Vlachaki, Vassilios Perifanis, Jannis Kountouras, Christos Zavos, Maria Chatzidimitriou, Evdoxia Hatjiharissi, Athanasios Papadopoulos and George Ntaios and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and International Journal of Molecular Sciences.

In The Last Decade

Michael D. Diamantidis

39 papers receiving 300 citations

Peers

Michael D. Diamantidis
Mona Doshi United States
Nigel Heaton United Kingdom
Uğur Şahin Türkiye
A. Torres Spain
Michael D. Diamantidis
Citations per year, relative to Michael D. Diamantidis Michael D. Diamantidis (= 1×) peers Raheel Iftikhar

Countries citing papers authored by Michael D. Diamantidis

Since Specialization
Citations

This map shows the geographic impact of Michael D. Diamantidis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Diamantidis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Diamantidis more than expected).

Fields of papers citing papers by Michael D. Diamantidis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Diamantidis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Diamantidis. The network helps show where Michael D. Diamantidis may publish in the future.

Co-authorship network of co-authors of Michael D. Diamantidis

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Diamantidis. A scholar is included among the top collaborators of Michael D. Diamantidis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Diamantidis. Michael D. Diamantidis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Diamantidis, Michael D.. (2025). Factors affecting response and resistance to venetoclax in acute myeloid leukemia. Frontiers in Oncology. 15. 1577908–1577908. 1 indexed citations
2.
Diamantidis, Michael D.. (2024). Myeloid Sarcoma: Novel Advances Regarding Molecular Pathogenesis, Presentation and Therapeutic Options. Journal of Clinical Medicine. 13(20). 6154–6154. 1 indexed citations
3.
Mainou, Maria, Michael D. Diamantidis, Alexandra Kourakli, et al.. (2024). A Cross-Sectional, Multicentric, Disease-Specific, Health-Related Quality of Life Study in Greek Transfusion Dependent Thalassemia Patients. Healthcare. 12(5). 524–524. 3 indexed citations
4.
Vlachaki, Efthymia, Michael D. Diamantidis, Despina Papadopoulou, et al.. (2024). Prospective study of complement activation and thromboinflammation within sickle cell disease and its complications. HemaSphere. 8(7). e135–e135.
5.
Diamantidis, Michael D., et al.. (2024). Genetic Modifiers of Hemoglobin Expression from a Clinical Perspective in Hemoglobinopathy Patients with Beta Thalassemia and Sickle Cell Disease. International Journal of Molecular Sciences. 25(22). 11886–11886. 3 indexed citations
6.
Diamantidis, Michael D., et al.. (2023). Concomitant Presence of Hb Agrinio and - -Med Deletion in a Greek Male Patient with Hemoglobinopathy H: More Severe Phenotype and Literature Review. SHILAP Revista de lepidopterología. 15(3). 483–490. 1 indexed citations
9.
Diamantidis, Michael D., et al.. (2022). The Effect of COVID-19 on Hemoglobinopathy Patients’ Daily Lives While Quarantined: Four Greek Hospitals’ Experiences. SHILAP Revista de lepidopterología. 12(2). 39–45. 1 indexed citations
10.
Diamantidis, Michael D., Sofia Papadaki, & Evdoxia Hatjiharissi. (2022). Exploring the current molecular landscape and management of multiple myeloma patients with the t(11;14) translocation. Frontiers in Oncology. 12. 934008–934008. 8 indexed citations
11.
Diamantidis, Michael D., Maria Papaioannou, & Evdoxia Hatjiharissi. (2021). Primary gastric non-Hodgkin lymphomas: Recent advances regarding disease pathogenesis and treatment. World Journal of Gastroenterology. 27(35). 5932–5945. 6 indexed citations
12.
Diamantidis, Michael D., et al.. (2020). Hemophagocytic Lymphohistiocytosis as a Manifestation of Underlying Visceral Leishmaniasis. Cureus. 12(12). e11911–e11911. 7 indexed citations
13.
Diamantidis, Michael D., et al.. (2018). Massive bone marrow necrosis revealing an HIV-related primary bone marrow lymphoma: a diagnostic challenge. International Journal of Hematology. 109(1). 125–129. 1 indexed citations
14.
Perifanis, Vassilios, Michael D. Diamantidis, V. Kaloutsi, et al.. (2014). Concurrent presentation of nodal myeloid sarcoma and bone marrow chronic lymphocytic leukemia/small lymphocytic lymphoma: a unique association. International Journal of Hematology. 99(4). 508–512. 2 indexed citations
15.
Kaiafa, Georgia, Vassilios Perifanis, Michael D. Diamantidis, et al.. (2011). Aberrant expression of myeloid and B cell markers in an aggressive multiple-site myeloid sarcoma. Annals of Hematology. 91(7). 1157–1159. 4 indexed citations
16.
Diamantidis, Michael D., et al.. (2010). Aggressive Systemic Mastocytosis Associated with Mesangioproliferative Glomerulonephritis. Acta Haematologica. 125(3). 153–159. 4 indexed citations
17.
Diamantidis, Michael D., Athanasios Papadopoulos, Georgia Kaiafa, et al.. (2009). Differential diagnosis and treatment of primary, cutaneous, anaplastic large cell lymphoma: not always an easy task. International Journal of Hematology. 90(2). 226–229. 10 indexed citations
18.
Papadopoulos, Athanasios, George Ntaios, Georgia Kaiafa, et al.. (2008). Veno-occlusive disease of the liver during induction therapy for acute lymphoblastic leukemia. International Journal of Hematology. 88(4). 441–442. 7 indexed citations
19.
Kountouras, Jannis, et al.. (2008). New Aspects of Regulatory Signaling Pathways and Novel Therapies in Pancreatic Cancer. Current Molecular Medicine. 8(1). 12–37. 19 indexed citations
20.
Papadopoulos, Athanasios, George Ntaios, Georgia Kaiafa, et al.. (2008). Increased incidence of iron deficiency anemia secondary to inadequate iron intake in institutionalized, young patients with cerebral palsy. International Journal of Hematology. 88(5). 495–497. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026